Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents
- Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents
- 오창현; 모하메드 사미르; 마그디 아마르
- MAPK; RAF 억제제; Anti-Cancer agents
- Issue Date
- European journal of medicinal chemistry
- VOL 158-166
- Frequent oncogenic mutations have been identified in MAPK (mitogen-activated protein kinase) signaling pathway components. As a result, MAPK pathway is associated with human cancer initiation, in particular RAF (rapidly accelerated fibrosarcoma) component. The mutation in RAF component leads to auto-activation of MAPK signaling pathway, stimulating the uncontrolled cell growth and proliferation. In last few years, diverse chemical scaffolds have been identified as RAF inhibitors. Most of these scaffolds show potent anti-cancer activity. The present review highlights the recent investigations of RAF inhibitors during the last five years.
- Appears in Collections:
- KIST Publication > ETC
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.